|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 88, 238-247, Copyright © 1984 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
BD Foltz, EA Hessel 2d and TD Ivey
In an effort to describe the immediate course of pulmonary hypertension
following mitral valve replacement, we reviewed preoperative and
postoperative data from 62 patients who underwent mitral valve replacement.
Patients were divided based on the absence (Group I) or presence (Group II)
of severe preoperative pulmonary hypertension, defined as a mean pulmonary
artery pressure greater than or equal to 40 mm Hg. Group II patients were
subdivided based on the absence (Group IIa) or presence ( Group IIb) of
markedly elevated preoperative pulmonary vascular resistance indices,
defined as a greater than or equal to 700 dynes . sec . cm-5 . m2.
Pulmonary artery wedge pressures fell promptly following mitral valve
replacement in all groups, but the course of other hemodynamic parameters
varied among groups. Cardiac index increased significantly among Group I
and IIb patients but not among Group IIa patients. Group I patients did not
have significant changes in mean pulmonary artery pressure and pulmonary
vascular resistance index. Group IIa patients had substantial reductions in
mean pulmonary artery pressure while pulmonary vascular resistance index
remained near 400 dynes . sec . cm-5 . m2. Group IIb patients had
substantial reductions in mean pulmonary artery pressure while pulmonary
vascular resistance index fell significantly to about 400 dynes . sec .
cm-5 . m2. Primary valvular lesion and pharmacologic support were
insignificant variables. Data from these hemodynamic groups suggest that at
least three mechanisms contribute to the pulmonary hypertension seen in
mitral valve disease: passive transmission of elevated left atrial
pressures, reactive pulmonary arteriolar vasoconstriction, and morphologic
changes in the pulmonary vasculature. The first two mechanisms appear to be
rapidly reversed following mitral valve replacement. While others have
described the regression of pulmonary hypertension several months following
mitral valve operations, data presented here suggest that changes in
pulmonary artery pressures and pulmonary vascular resistance index may
occur much earlier.
ARTICLES
The early course of pulmonary artery hypertension in patients undergoing mitral valve replacement with cardioplegic arrest
This article has been cited by other articles:
![]() |
M. Mubeen, A. K Singh, S. K Agarwal, J. Pillai, S. Kapoor, and A. K Srivastava Mitral Valve Replacement in Severe Pulmonary Arterial Hypertension Asian Cardiovasc Thorac Ann, February 1, 2008; 16(1): 37 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Cesnjevar, R. Feyrer, F. Walther, F. O. Mahmoud, Y. Lindemann, and J. von der Emde High-risk mitral valve replacement in severe pulmonary hypertension--30 years experience Eur. J. Cardiothorac. Surg., April 1, 1999; 13(4): 344 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sagie, E. Schwammenthal, I. F. Palacios, M. E. King, M. Leavitt, N. Freitas, A. E. Weyman, and R. A. Levine Significant tricuspid regurgitation does not resolve after percutaneous balloon mitral valvotomy J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 727 - 735. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |